Irbesartan Tablet
Product Images NDC 50090-7622

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 50090-7622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907622)

Packaging label for Irbesartan 300 mg oral tablets, distributed by A-S Medication Solutions, Libertyville, IL. The label indicates 90 tablets per package with storage instructions to keep at 68 to 77 degrees Fahrenheit. Includes the product NDC 50090-7622 and dosage form as tablets.*

FDA Label Image

Structure (Spl Image1 Structure)

Chemical structure of Irbesartan depicted as a molecular diagram showing its fused ring systems and side chains.*

FDA Label Image

Figure 1 (Spl Image2 Figure1)

A scatter plot with a trend line showing the relationship between Irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeSBP (mmHg) on the y-axis, illustrating dose-response data from an integrated analysis.*

FDA Label Image

Figure 2 (Spl Image3 Figure2)

A chart depicting the placebo-subtracted reduction in trough SeDBP (systolic eardrum blood pressure) as a function of Irbesartan dose in mg per day, showing data points and a fitted curve illustrating the dose-response relationship.*

FDA Label Image

Figure 3 (Spl Image4 Figure3)

A Kaplan-Meier cumulative event rate graph comparing Irbesartan, Amlodipine, and Placebo over months of follow-up. The y-axis shows cumulative event rate (%) and the x-axis shows months from 0 to 60. Irbesartan exhibits a lower cumulative event rate than both Amlodipine and Placebo across the follow-up period. A legend box includes relative risk (RR) and p-values for Irbesartan versus Placebo (RR 0.80, P 0.0234) and Irbesartan versus Amlodipine (RR 0.77, P 0.0064).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.